Attitudes toward, and interest in, the test-and-treat strategy for HIV prevention among Thai men who have sex with men

AIDS Care. 2014;26(10):1298-302. doi: 10.1080/09540121.2014.911810. Epub 2014 Apr 28.

Abstract

This study assessed the attitudes toward, and interest in, the test-and-treat strategy, comprising regular HIV testing and immediate antiretroviral treatment (ART) among men who have sex with men (MSM) in Bangkok, Thailand. A total of 363 participants completed the questionnaires before and after learning about their HIV status. Previous HIV testing reported by 69.8% and 34.7% tested at least annually. Before pretest counseling, 83.2% expressed interest in regular HIV testing and 78.8% in immediate ART. MSM who tested HIV-positive at enrollment were less likely than those who tested HIV-negative to have been tested for HIV before (45.7% vs. 60.8%, p < 0.0001). Among MSM who tested HIV-positive (n = 69, 15.9%), the median level of willingness to take ART immediately increased significantly after learning about their positive results (90 vs.100%, p < 0.0001). Interest in regular HIV testing remained high among HIV-negative MSM after becoming aware of their status (70.9% before vs. 71.9% after, p = 0.55). MSM participants have a strong desire and willingness to start ART immediately upon receiving an HIV-positive test result; it is important to provide the necessary information on the health benefits of early ART and education to the community to maintain their health and prevent HIV transmission.

Keywords: HIV testing; MSM; attitudes; immediate antiretroviral therapy; test-and-treat strategy.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Attitude to Health*
  • HIV Infections / drug therapy
  • HIV Infections / prevention & control*
  • HIV Infections / psychology*
  • HIV Seropositivity / diagnosis
  • HIV Seropositivity / drug therapy
  • Health Knowledge, Attitudes, Practice*
  • Homosexuality, Male / psychology*
  • Humans
  • Male
  • Surveys and Questionnaires
  • Thailand
  • Young Adult

Substances

  • Anti-HIV Agents